Neurona Therapeutics Announces Initial Subject Dosed in First Clinical Trial of Regenerative Human Cell Therapy, NRTX-1001, in Adults with Drug-Resistant Focal Epilepsy
Neurona has initiated dosing of a first-ever regenerative human cell therapy candidate in a Phase…
i10X launches Superagent
CTO Confidence in Scaling AI Falls for Third Straight Year, Akkodis Report Finds
CTO Confidence in Scaling AI Falls for Third Straight Year, Akkodis Report Finds
Anker Innovations announces the listing plan on the Main Board of HKEX with a maximum fundraising of HK$4,631.6 Million*